Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18540265 | 0.90 | MAOB (0.34) | HTR2AHTR2CFFAR1FFAR4MAOB | |
| SCHEMBL18540221 | 0.89 | HTR2A (0.35) | HTR2AHTR2CFFAR1FFAR4MAOB | |
| SCHEMBL18540056 | 0.89 | HTR2A (0.39) | HTR2AHTR2CFFAR1FFAR4 | |
| SCHEMBL18540259 | 0.87 | RARB (0.39) | FFAR1FFAR4TAAR1 | |
| SCHEMBL18540138 | 0.87 | RARB (0.37) | — | |
| SCHEMBL18540216 | 0.86 | HTR2A (0.36) | HTR2AHTR2CMAOBTAAR1 | |
| SCHEMBL18540270 | 0.85 | RARB (0.36) | HTR2A | |
| SCHEMBL18540256 | 0.85 | RARB (0.37) | FFAR1FFAR4MAOBTAAR1 | |
| SCHEMBL18540271 | 0.85 | TAAR1 (0.36) | HTR2AHTR2CFFAR1FFAR4MAOB | |
| SCHEMBL18540200 | 0.85 | RARB (0.36) | FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170051206-A1 | LIQUID CRYSTAL COMPOUND HAVING ALKENYL ON BOTH ENDS, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2017-02-23 | — | — | US | disclosed |
| US-20170051206-A1 | LIQUID CRYSTAL COMPOUND HAVING ALKENYL ON BOTH ENDS, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2017-02-23 | — | — | US | disclosed |
| US-9120795-B2 | Crystalline form of a β-lactamase inhibitor | CUBIST PHARMACEUTICALS, INC. (US) | 2015-09-01 | — | — | US | disclosed |